Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.
Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, McGregor BA, Harvey K, Tai M, Kollefrath A, Thomas BJ, Sorta D, Kaelen M, Kelmendi B, Gooley TA
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (10)
- Psychedelic assisted psychotherapy (2020-2025): a scoping review of clinical evidence, mechanisms, safety, and ethics 2026-10-27 · Expand citations
- Study participant perceptions of the relevance of therapist and study team personal psychedelic experience 2026-10-03 · Expand citations
- Psilocybin for Fear of Cancer Recurrence 2026-08-01 · Expand citations
- Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview 2026-07-13 · Expand citations
- Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA 2026-06-15 · Expand citations
- The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus 2026-05-07 · Expand citations
- The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes 2026-04-21 · Expand citations
- A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression 2026-04-06 · Expand citations
- Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
- Psilocybin or Nicotine Patch for Smoking Cessation 2026-03-10 · Expand citations